valine has been researched along with Head and Neck Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, X; Dong, Y; Gu, W; Song, X; Wang, Z; Wu, Y; Zhang, W; Zheng, Y; Zhong, Y | 1 |
Angelidakis, G; Blechacz, B; Economides, MP; Granwehr, BP; Hosry, J; Jiang, Y; Kaseb, A; Kyvernitakis, A; Mahale, P; Miller, E; Naing, A; Raad, II; Samaniego, F; Torres, HA | 1 |
Imagawa, Y; Kimura, S; Satake, K; Tsukuda, M | 1 |
Athanassiadou, P; Dardoufas, K; Gonidi, M; Kolitsi, G; Kouloulias, V; Kouvaris, J; Kyprianou, K; Nicolatou-Galitis, O; Papanikolaou, IS; Pissakas, G; Polychronopoulou, A; Skarleas, C; Sotiropoulou-Lontou, A | 1 |
An, J; El-Naggar, AK; Hu, Z; Li, G; Liu, Z; Spitz, MR; Sturgis, EM; Wang, LE; Wei, Q | 1 |
Andrews, NC; Aust, JB; Lawton, RL; Schroeder, JM | 1 |
1 trial(s) available for valine and Head and Neck Neoplasms
Article | Year |
---|---|
Clinical note. Phase II study of 1-aminocyclopentanecarboxylic acid (NSC-1026) in patients with cancer.
Topics: Amino Acids; Clinical Trials as Topic; Colonic Neoplasms; Cyclopentanes; Evaluation Studies as Topic; Feeding and Eating Disorders; Head and Neck Neoplasms; Humans; Leiomyosarcoma; Male; Neoplasms; Rectal Neoplasms; Sarcoma; Testicular Neoplasms; Valine; Vomiting | 1970 |
5 other study(ies) available for valine and Head and Neck Neoplasms
Article | Year |
---|---|
Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasm Invasiveness; Signal Transduction; Tetrahydronaphthalenes; Tumor Burden; Valine; Xenograft Model Antitumor Assays | 2018 |
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.
Topics: Aged; Antiviral Agents; Benzimidazoles; Breast Neoplasms; Carbamates; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluorenes; Head and Neck Neoplasms; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Interferons; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Neoplasms; Polyethylene Glycols; Prospective Studies; Pyrrolidines; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine | 2019 |
The relationship of the human glutathione S-transferase P1 polymorphism and chemotherapeutic sensitivity in head and neck squamous carcinoma.
Topics: Alleles; Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Multiple; Exons; Genotype; Glutathione Transferase; Head and Neck Neoplasms; Heterozygote; Humans; Inhibitory Concentration 50; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Tetrazolium Salts; Thiazoles; Valine | 2004 |
Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis.
Topics: Abnormalities, Radiation-Induced; Acyclovir; Adult; Aged; Aged, 80 and over; Antiviral Agents; Candidiasis, Oral; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Herpes Simplex; Herpesvirus 1, Human; Humans; Incidence; Male; Middle Aged; Oral Ulcer; Radiotherapy; Recurrence; Stomatitis; Treatment Outcome; Valacyclovir; Valine | 2006 |
Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
Topics: Age Factors; Aged; Carcinoma, Squamous Cell; Case-Control Studies; DNA Repair; DNA-Binding Proteins; Female; Gene Frequency; Genes, Recessive; Genetic Predisposition to Disease; Genetic Variation; Genotype; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Sex Factors; Transglutaminases; Valine | 2007 |